• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Granules India Ltd.
    30 Jan 2025
    543.40
    0.05%
    Granules India gets USFDA's nod forADHD generic
    Business Line
    With this latest approval, Granules India Ltd Limited now holds a total of 69 ANDA approvals, with 38 secured under the name of Granules India Limited (GIL) and 31 under Granules Pharmaceuticals, Inc. (GPI)
    Copy LinkShare onShare on Share on Share on
    Geojit BNP Paribas increased Accumulate price target of Granules India Ltd. to 630.0 on 18 Sep, 2025.
    Granules India Gets USFDA Nod For Capsules That Treat ADHD
    NDTV Profit | 30 Jan 2025
    logo
    Bajaj Healthcare Ltd.
    30 Jan 2025
    423.65
    -0.74%
    Bajaj Healthcare Receives Nod From DCGA To Manufacture Drug For Parkinsons' Treatment
    Bajaj Healthcare Receives Nod From DCGA To Manufacture Drug For Parkinsons' Treatment
    NDTV Profit
    Pimavanserin, marketed globally as Nuplazid, has become a preferred treatment in the US antipsychotic segment.
    Copy LinkShare onShare on Share on Share on
    Bajaj Healthcare Ltd. is trading below all available SMAs
    logo
    Blue Jet Healthcare Ltd
    30 Jan 2025
    679.45
    -0.56%
    This smallcap stock surges 21% in 2 days; zooms 101% against issue price
    Business Standard
    Shares of Blue Jet Healthcare hit a new high of Rs 695.55, and were locked in the 10% upper circuit after the firm reported robust earnings in the December quarter.
    Copy LinkShare onShare on Share on Share on
    Blue Jet Healthcare Ltd has lost -25.40% in the last 6 Months
    logo
    Piramal Pharma Ltd.
    30 Jan 2025
    208.28
    2.43%
    Piramal Pharma to expand injectables portfolio in complex hospital generics business
    Piramal Pharma to expand injectables portfolio in complex hospital generics business
    livemint
    Piramal Pharma launched Chlorpromazine Hydrochloride in the US last week. The company reported a 14% growth in its complex hospital generics business, led by strong sales in inhalation anaesthesia, despite pricing pressures.
    Copy LinkShare onShare on Share on Share on
    Piramal Pharma Ltd. is trading above its 150 day SMA of 204.9
    CDMO revenues to touch $1.2 bn by FY30: Piramal Pharma chairperson
    Business Standard | 29 Jan 2025
    Z
    Zenotech Laboratories Ltd.
    30 Jan 2025
    52.54
    -0.70%
    Zenotech Laboratories Q3 Results 2025 on 30 Jan, 2025: profit falls by 49.7% YOY, profit at 1.69 crore and revenue at 11.24 crore
    Zenotech Laboratories Q3 Results 2025 on 30 Jan, 2025: profit falls by 49.7% YOY, profit at 1.69 crore and revenue at 11.24 crore
    livemint
    Zenotech Laboratories Q3 Results 2025 on 30 Jan, 2025: Revenue increased by 2.74% YoY & profit decreased by 49.7% YoY, profit at 1.69 crore and revenue at 11.24 crore
    Copy LinkShare onShare on Share on Share on
    Zenotech Laboratories Ltd. average weekly volume is high.
    logo
    Novartis India Ltd.
    30 Jan 2025
    906.35
    0.67%
    Novartis India Q3 Results 2025 on 30 Jan, 2025: profit falls by 4.22% YOY, profit at 25.45 crore and revenue at 93 crore
    Novartis India Q3 Results 2025 on 30 Jan, 2025: profit falls by 4.22% YOY, profit at 25.45 crore and revenue at 93 crore
    livemint
    Novartis India Q3 Results 2025 on 30 Jan, 2025: Revenue increased by 10.01% YoY & profit decreased by 4.22% YoY, profit at 25.45 crore and revenue at 93 crore
    Copy LinkShare onShare on Share on Share on
    Novartis India Ltd. is trading below all available SMAs
    logo
    Piramal Pharma Ltd.
    29 Jan 2025
    208.28
    2.43%
    Piramal Pharma looks to the next few months with cautious optimism, says Nandini Piramal
    Business Line
    Given the geopolitical uncertainty and directives from the new administration in the United States.
    Copy LinkShare onShare on Share on Share on
    Piramal Pharma Ltd. is trading above its 150 day SMA of 204.9
    Piramal Pharma Q3 Results 2025: Profit Falls by 63.6% YoY
    livemint | 29 Jan 2025 1 more
    Piramal Pharma Q3 FY25 results: PAT falls 63% to Rs 3.6 cr, revenue up 12%
    Business Standard | 28 Jan 2025
    logo
    Sun Pharmaceutical Industries Ltd.
    29 Jan 2025
    1656.00
    0.45%
    Sun Pharma Q3 Preview: Profits may jump 13%, revenues to rise 10% YoY
    Business Standard
    According to brokerage estimates compiled by Business Standard, Sun Pharma may see its average revenue rise by 9.51 per cent year-on-year (Y-o-Y) to Rs 13,313 crore as against Rs 12,156 crore
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors decreased from 1351 to 1326 in Jun 2025 qtr
    logo
    Acutaas Chemicals Ltd.
    29 Jan 2025
    1458.10
    -0.88%
    Ami Organics share soars 18% in one day after profit jumps 155% in Q3
    Business Standard
    Ami Organics share price gained 17.69 per cent at Rs 2215.40 a piece on the BSE in Wednesday's intraday trade after the company delivered a significant rise in revenues and profit for Q3FY25
    Copy LinkShare onShare on Share on Share on
    Acutaas Chemicals Ltd. has gained 23.59% in the last 6 Months
    J
    Jenburkt Pharmaceuticals Ltd.
    29 Jan 2025
    1106.80
    -1.35%
    Jenburkt Pharmaceuticals Q3 Results 2025 on 29 Jan, 2025: profit rise by 20.56% YOY, profit at 6.51 crore and revenue at 36.89 crore
    Jenburkt Pharmaceuticals Q3 Results 2025 on 29 Jan, 2025: profit rise by 20.56% YOY, profit at 6.51 crore and revenue at 36.89 crore
    livemint
    Jenburkt Pharmaceuticals Q3 Results 2025 on 29 Jan, 2025: Revenue increased by 3.45% YoY & profit increased by 20.56% YoY, profit at 6.51 crore and revenue at 36.89 crore
    Copy LinkShare onShare on Share on Share on
    Jenburkt Pharmaceuticals Ltd. is trading at high day volume of 2536.00000.
    more
    loading
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • JD Cables
    • GK Energy
    • Siddhi Cotspin
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2025 Giskard Datatech Pvt Ltd